NASH-TAG 2021
March 11-13, 2021
To help you get as much value from NASH-TAG 2021 as possible, we have identified several presentations and articles we find most interesting. Our daily podcasts will summarize these and discuss what they suggest for the future of NASH/NAFLD therapies.
Advanced Notification
S3-E41 – Improving NASH Clinical Trials By Reducing Screen Fail Rates
Jörn Schattenberg joins Stephen Harrison, Louise Campbell and Roger Green to talk NASH Clinical Trials, improving screen fail rates, and finding more patients.
S3-E40.5 – From the Vault: Why Cirrhosis Matters In Clinical Trial Strategy
This episode discusses the unique role NASH cirrhosis studies can play in clinical trial design, particularly in the transition from biopsy as gold standard to a post-biopsy world. Stephen Harrison starts this conversation by discussing why we focus on NASH cirrhosis and goes on to review the recent presentation of results from the REVERSE study on obeticholic acid. Jörn Schattenberg and Mazen Noureddin add their perspectives to the conversation.
S3-E40.4 – Challenges of Alcohol Screening in Fatty Liver Disease
Co-authors Michelle Long and Mazen Noureddin join Louise Campbell and Roger Green to discuss their recent publication on Best Practice in lean NASH. This conversation focuses on the challenges of alcohol screening when assessing a patient for Fatty Liver disease.
S3-E40.3 – Importance of Early Diagnosis in Lean NASH
Co-authors Michelle Long and Mazen Noureddin join Louise Campbell and Roger Green to discuss their recent publication on Best Practice in lean NASH. This conversation focuses on why early diagnosis is so important when dealing with Lean NASH.
S3-E40.2 – A Simple Diagnostic Algorithm for Lean NASH
Co-authors Michelle Long and Mazen Noureddin join Louise Campbell and Roger Green to discuss their recent publication on Best Practice in lean NASH. This conversation focuses on the elegant one-page diagnostic algorithm they recommend for diagnosing Lean NASH in “normal” BMI patients with signs of liver disease.
S3-E40.1 – Best Practices in Lean NASH: How the Article Came About
Co-authors Michelle Long and Mazen Noureddin join Louise Campbell and Roger Green to discuss their recent publication on Best Practice in lean NASH. This conversation focuses on how this article came to be and the key steps in researching and writing it.
